Long-term survival using intra-aortic balloon pump and percutaneous right ventricular assist device for biventricular mechanical support of cardiogenic shockBrett D Atwater
Division of Cardiovascular Medicine, University of Wisconsin Madison, 321 S Owen Drive, Madison, WI 53705, USA
J Invasive Cardiol 20:E205-7. 2008
..Further evaluation of completely percutaneous biventricular support in acute MI is warranted...
The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable anginaBrett D Atwater
Division of Cardiovascular Medicine, Duke University Medical Center, Durham, North Carolina 27713, USA
Clin Cardiol 32:E1-3. 2009
..The impact of these findings on clinical practice remains unknown...
Pulmonary vein contraction before and after radiofrequency ablation for atrial fibrillationBrett D Atwater
Division of Cardiovascular Medicine, Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina, USA
J Cardiovasc Electrophysiol 22:169-74. 2011
....
Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindicationsBrett D Atwater
Duke University Medical Center, Durham, NC Durham Veterans Administration Medical Center, Durham, NC Electronic address
Am Heart J 164:750-755.e1. 2012
..Several studies based on claims data have reported underutilization of evidence-based heart failure (HF) therapies. The degree to which these estimates fail to account for therapeutic contraindications is unclear...
Implantable cardioverter defibrillators: risks accompany the life-saving benefitsBrett D Atwater
Electrophysiology Section, Cardiology Division, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Centre, Durham, NC 27710, USA
Heart 98:764-72. 2012
..This commentary summarises the weaknesses, disadvantages and risks of the ICD in a balanced fashion in light of their proven life-saving benefits...
Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunctionNancy M Allen LaPointe
Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27705, USA
Circ Cardiovasc Qual Outcomes 4:146-51. 2011
..The extent and documented reasons for nonuse of ICDs among patients with left ventricular systolic dysfunction are unknown...
Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablationThomas W Wallace
Duke Center for Atrial Fibrillation, Cardiac Electrophysiology Section of the Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA
J Cardiovasc Electrophysiol 21:849-52. 2010
..Catheter-directed atrial fibrillation (AF) ablation is contraindicated among patients with left atrial appendage (LAA) thrombus. The prevalence of LAA thrombus among fully anticoagulated patients undergoing AF ablation is unknown...
Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery diseaseBrett D Atwater
Duke Clinical Research Institute, Durham, NC, USA
Am J Cardiol 104:1624-30. 2009
....
Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromesBrett D Atwater
University of Wisconsin Madison, Madison, Wisconsin, USA
Am J Cardiol 100:1727-33. 2007
..In conclusion, more widespread measurement of BNP levels for risk stratification of patients with NSTE ACS may be warranted...
Fulminant myopericarditis from phenytoin-induced systemic lupus erythematosusBrett D Atwater
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Wisconsin Hospitals and Clinics, Madison, WI 53705, USA
WMJ 107:298-300. 2008
..We present an unusual case of drug-induced lupus from chronic phenytoin use in a man who presented with symptoms of fulminant myopericarditis. To our knowledge, this is the first such case reported in English...
Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selectionBrett D Atwater
Duke Clinical Research Institute, Durham, North Carolina 27705, USA
Drugs 65:313-24. 2005
....